Literature DB >> 8133912

Evans blue blocks P2X-purinoceptors in rat vas deferens.

R Bültmann1, K Starke.   

Abstract

In rat vas deferens, Evans blue 100 microM increased contractions elicited by high K+ and by noradrenaline but markedly reduced contractions elicited by the P2X-purinoceptor-selective agonist alpha,beta-methylene ATP (3 microM). The concentration-response curve of alpha,beta-methylene ATP was shifted to the right by Evans blue 30 microM and the maximal contraction was increased. In tissues incubated with nifedipine 10 microM, Evans blue 100 microM tended to increase the residual contraction elicited by noradrenaline and abolished the residual response to alpha, beta-methylene ATP (3 microM). The concentration-response curve of alpha,beta-methylene ATP was progressively shifted to the right by increasing concentrations of Evans blue in the presence of nifedipine; maximal contractions were increased by Evans blue 10 and 30 but not 100 microM. From the shifts to the right caused by Evans blue 30 microM, apparent pKB values of 5.9 (no nifedipine) and 6.0 (nifedipine present) were calculated. It is concluded that Evans blue blocks P2X-purinoceptors in rat vas deferens and in addition causes a non-receptor-specific enhancement of contractions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8133912     DOI: 10.1007/bf00167248

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Interaction of adenine nucleotides, UTP and suramin in mouse vas deferens: suramin-sensitive and suramin-insensitive components in the contractile effect of ATP.

Authors:  I von Kügelgen; R Bültmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.

Authors:  G Lambrecht; T Friebe; U Grimm; U Windscheif; E Bungardt; C Hildebrandt; H G Bäumert; G Spatz-Kümbel; E Mutschler
Journal:  Eur J Pharmacol       Date:  1992-07-07       Impact factor: 4.432

3.  Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.

Authors:  P M Dunn; A G Blakeley
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

Review 4.  Is there a basis for distinguishing two types of P2-purinoceptor?

Authors:  G Burnstock; C Kennedy
Journal:  Gen Pharmacol       Date:  1985

Review 5.  Fitting curves to data using nonlinear regression: a practical and nonmathematical review.

Authors:  H J Motulsky; L A Ransnas
Journal:  FASEB J       Date:  1987-11       Impact factor: 5.191

6.  P2-purinoceptor antagonists discriminate three contraction-mediating receptors for ATP in rat vas deferens.

Authors:  R Bültmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.

Authors:  N Mallard; R Marshall; A Sithers; B Spriggs
Journal:  Eur J Pharmacol       Date:  1992-09-10       Impact factor: 4.432

9.  P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y-but not the P2x-purinoceptor.

Authors:  G Burnstock; J J Warland
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

10.  Co-transmission in the rat vas deferens: postjunctional synergism of noradrenaline and adenosine 5'-triphosphate.

Authors:  J P Huidobro-Toro; S Parada
Journal:  Neurosci Lett       Date:  1988-03-10       Impact factor: 3.046

View more
  13 in total

1.  Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.

Authors:  R Bültmann; O Dudeck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

2.  P2-purinoceptor antagonists: II. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to Evans blue and trypan blue.

Authors:  H Wittenburg; R Bültmann; B Pause; C Ganter; G Kurz; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

3.  Failure of tyramine to release neuronal ATP as a cotransmitter of noradrenaline in the guinea-pig vas deferens.

Authors:  B Driessen; J Gonçalves; B Szabo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

Review 4.  New insights on P2X purinoceptors.

Authors:  P P Humphrey; G Buell; I Kennedy; B S Khakh; A D Michel; A Surprenant; D J Trezise
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

5.  ATP: The crucial component of secretory vesicles.

Authors:  Judith Estévez-Herrera; Natalia Domínguez; Marta R Pardo; Ayoze González-Santana; Edward W Westhead; Ricardo Borges; José David Machado
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-24       Impact factor: 11.205

6.  P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin.

Authors:  R Bültmann; H Wittenburg; B Pause; G Kurz; P Nickel; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

7.  De novo expression of connexin hemichannels in denervated fast skeletal muscles leads to atrophy.

Authors:  Luis A Cea; Bruno A Cisterna; Carlos Puebla; Marina Frank; Xavier F Figueroa; Christopher Cardozo; Klaus Willecke; Ramón Latorre; Juan C Sáez
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  Functional consequences of inhibition of nucleotide breakdown in rat vas deferens: a study with Evans blue.

Authors:  R Bültmann; B Driessen; J Gonçalves; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

9.  Mechanism of bradykinin-induced plasma extravasation in the rat knee joint.

Authors:  H Cambridge; S D Brain
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

10.  Blockade of P2X-purinoceptors by trypan blue in rat vas deferens.

Authors:  R Bültmann; M Trendelenburg; K Starke
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.